ATE113837T1 - Mittel zur bekämpfung des schmerzes, der depression und zur beruhigung. - Google Patents

Mittel zur bekämpfung des schmerzes, der depression und zur beruhigung.

Info

Publication number
ATE113837T1
ATE113837T1 AT86902214T AT86902214T ATE113837T1 AT E113837 T1 ATE113837 T1 AT E113837T1 AT 86902214 T AT86902214 T AT 86902214T AT 86902214 T AT86902214 T AT 86902214T AT E113837 T1 ATE113837 T1 AT E113837T1
Authority
AT
Austria
Prior art keywords
depression
calm
agents
compositions
combat pain
Prior art date
Application number
AT86902214T
Other languages
English (en)
Inventor
Martin G Crosby
Original Assignee
Serotonin Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serotonin Ind filed Critical Serotonin Ind
Application granted granted Critical
Publication of ATE113837T1 publication Critical patent/ATE113837T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Manufacture Of Tobacco Products (AREA)
AT86902214T 1985-03-26 1986-03-21 Mittel zur bekämpfung des schmerzes, der depression und zur beruhigung. ATE113837T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71610085A 1985-03-26 1985-03-26
US06/755,367 US4596807A (en) 1985-03-26 1985-07-16 Method and compositions for controlling pain, depression and sedation

Publications (1)

Publication Number Publication Date
ATE113837T1 true ATE113837T1 (de) 1994-11-15

Family

ID=27109475

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86902214T ATE113837T1 (de) 1985-03-26 1986-03-21 Mittel zur bekämpfung des schmerzes, der depression und zur beruhigung.

Country Status (7)

Country Link
US (1) US4596807A (de)
EP (1) EP0222782B1 (de)
AT (1) ATE113837T1 (de)
AU (1) AU586859B2 (de)
DE (1) DE3650138D1 (de)
GR (1) GR860762B (de)
WO (1) WO1986005684A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0172004B1 (de) * 1984-08-15 1990-03-21 The Boots Company PLC Chinolinone, Verfahren zu ihrer Herstellung und die sie enthaltenden pharmazeutischen Präparate
US4833154A (en) * 1987-12-14 1989-05-23 Jean Louis Louis J Natural sleeping pill to prevent and alleviate insomnia
JPH0395115A (ja) * 1989-06-15 1991-04-19 Taisho Pharmaceut Co Ltd 鎭咳剤
US5589511A (en) * 1990-08-13 1996-12-31 Sepracor Inc. Method for treating migraine headaches using optically pure S(+) fluoxetine
US5104899A (en) * 1990-08-13 1992-04-14 Sepracor, Inc. Methods and compositions for treating depression using optically pure fluoxetine
US5708035A (en) * 1991-02-04 1998-01-13 Sepracor Inc. Methods of use and compositions of R(-) fluoxetine
US5512593A (en) * 1993-03-02 1996-04-30 John S. Nagle Composition and method of treating depression using natoxone or naltrexone in combination with a serotonin reuptake inhibitor
AU2265695A (en) * 1995-01-17 1996-08-07 Pfizer Inc. The use of sertraline to treat cancer patients
US6017946A (en) * 1997-10-08 2000-01-25 Posner; Robert Serotonin containing formulation for oral administration and method of use
US5939076A (en) * 1997-11-12 1999-08-17 Allocca Techical, Inc. Composition and method for treating or alleviating migraine headaches
US6176242B1 (en) 1999-04-30 2001-01-23 Medtronic Inc Method of treating manic depression by brain infusion
ATE305788T1 (de) * 1999-07-01 2005-10-15 Pharmacia & Upjohn Co Llc (s,s)-reboxetin zur behandlung von inkontinenz
US6403657B1 (en) * 1999-10-04 2002-06-11 Martin C. Hinz Comprehensive pharmacologic therapy for treatment of obesity
US6871098B2 (en) * 2000-10-30 2005-03-22 Medtronic, Inc. Method for treating obsessive-compulsive disorder with electrical stimulation of the brain internal capsule
US7034059B2 (en) * 2001-07-02 2006-04-25 Sepracor Inc. Methods of using norfluoxetine
AUPR626201A0 (en) * 2001-07-10 2001-08-02 Bioscreen Pty Ltd A composition for use in prophylaxis and/or treatment
US20030087938A1 (en) * 2001-07-31 2003-05-08 Robertson David W. Treatment of chronic pain with 3-heterocycloxy-and 3-cycloalkyloxy-3-phenylpropanamines
BR0211522A (pt) * 2001-07-31 2004-09-14 Upjohn Co Tratamento de dor crÈnica com 3-arilóxi-3-fenilpropanaminas
WO2003035095A1 (en) * 2001-10-19 2003-05-01 Maxim Pharmaceuticals, Inc. Use of histamine to treat liver disease
US20090311795A1 (en) * 2002-03-21 2009-12-17 Hinz Martin C Bilateral control of functions traditionally regulated by only serotonin or only dopamine
US20060110325A1 (en) * 2003-02-21 2006-05-25 Hinz Martin C Serotonin and catecholamine segment optimization technology
CA2479218A1 (en) * 2002-03-21 2003-10-02 Martin C. Hinz Serotonin and catecholamine system segment optimization technology
US20070293571A1 (en) * 2006-06-08 2007-12-20 Hinz Martin C Adminstration of dopa precursors with sources of dopa to effectuate optimal catecholamine neurotransmitter outcomes
AU2003261030A1 (en) * 2002-09-05 2004-03-29 Pantarhei Bioscience B.V. Use of a sri and vitamin b6 for the treatment of neurological and mental disorders
US20070117844A1 (en) * 2005-11-18 2007-05-24 Morillo Connie S 5-HTP combination therapy
JP2010540461A (ja) * 2007-09-24 2010-12-24 ハー・ルンドベック・アクチエゼルスカベット セロトニン二重作用化合物に関する併用療法
US9468611B2 (en) * 2012-09-27 2016-10-18 Relmada Therapeutics, Inc. d-Methadone for the treatment of psychiatric symptoms
US12637411B2 (en) 2019-01-30 2026-05-26 Mggm Llc Structurally modified opioids for prevention and treatment of diseases and conditions
RU2706700C1 (ru) * 2019-09-24 2019-11-20 Общество с ограниченной ответственностью "Научно-производственная компания "СКиФФ" Фармацевтическая композиция для коррекции поведения кошек и собак в стрессовых ситуациях

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1066857B (it) * 1965-12-15 1985-03-12 Acraf Derivati della s ipiazolo 4.3 a piridina e processi per la loro preparazione

Also Published As

Publication number Publication date
US4596807A (en) 1986-06-24
EP0222782B1 (de) 1994-11-09
AU586859B2 (en) 1989-07-27
WO1986005684A1 (en) 1986-10-09
DE3650138D1 (de) 1994-12-15
EP0222782A4 (de) 1987-08-12
GR860762B (en) 1986-07-21
AU5621586A (en) 1986-10-23
EP0222782A1 (de) 1987-05-27

Similar Documents

Publication Publication Date Title
DE3650138D1 (de) Mittel zur bekämpfung des schmerzes, der depression und zur beruhigung.
ATE398464T1 (de) Synergie zwischen apo-2 ligand und antikörper gegen her-2
ATE437867T1 (de) Substituierte indole zur modulierung von nfkb- aktivität
DE60028971D1 (de) Apo-2l rezeptor-agonist und cpt-11 synergie-effekt
ATE406882T1 (de) Zusammensetzungen zur normalisierung des zirkadianen rythmus
PT1014961E (pt) Tratamento da cefaleia de enxaqueca utilizando metoclopramida e um nsaid
TR200101481T2 (tr) Doğal bitkisel zaruri yağlar kullanan kanser tedavi kompozisyonu ve yöntemi.
EA200300354A1 (ru) Хинолиноновые производные в качестве ингибиторов тирозинкиназы
DE69621012D1 (de) VERWENDUNG VON NSAIDs ZUR BEHANDLUNG VON PLATTENEPITHELKARZINOM DER MUNDHÖHLE UND KEHLKOPF
ATE447952T1 (de) Synergistische kombination von pumafentrine und salmeterol
BR0016555A (pt) Composições farmacêuticas que proporcionam concentrações acrescidas de droga
PE20020521A1 (es) Compuestos heterociclicos sustituidos para tratar la resistencia a multiples drogas
DE60117605D1 (de) Thiazolyl-inhibitoren von tyrosinkinasen der tec-familie
BR9714415A (pt) Heterociclos contendo nitrogênio substituìdo como inibidores de proteìnas quinase p38
ATE259215T1 (de) Zusammensetzung zur regulierung des hauterscheinungsbildes
ES2177112T3 (es) Agentes angiostaticos y composiciones para tratar el glaucoma glc1a.
ES2163407T3 (es) Derivados piperidinilos tiaciclicos.
ATE344670T1 (de) Synergistische kombination zur behandlung von kolorektalkarzinom
ES2165586T3 (es) Derivados de isatina como inhibidores de acetilcolinesterasa y analgesicos.
DE69713300D1 (de) Benzopyran derivate mit leukotrien-antagonistischer wirkung
BR0208695A (pt) Composições e métodos para a prevenção e tratamento de c ncer humano da próstata
ATE200617T1 (de) Pharmazeutische zusammensetzungen zur transdermalen verabreichung von melatonin und/oder seine analoge
ATE435643T1 (de) Verbesserte lipidzusammensetzungen und darin enthaltene derivate des 3- methoxybenzylthioharnstoffs
MXPA06007007A (es) Derivados de prolina usados como ingredientes farmaceuticos activos para el tratamiento de tumores.
EA200200656A1 (ru) НОВЫЕ ТЕРАПЕВТИЧЕСКИЕ КОМБИНАЦИИ (S)-2-(БЕНЗИЛАМИНОМЕТИЛ)-2,3,8,9-ТЕТРАГИДРО-7H-1,4-ДИОКСИН [2,3-е]ИНДОЛ-8-ОНА И НЕЙРОЛЕПТИКОВ ДЛЯ ЛЕЧЕНИЯ ИЛИ ПРЕДОТВРАЩЕНИЯ ПСИХОТИЧЕСКИХ РАССТРОЙСТВ

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties